Back to search

Article

Chemo-sEVs release in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal function

2023-02-04

Abstract excerpt

<h4>ABSTRACT</h4> Ovarian cancer (OvCa) is an aggressive disease usually treated with cisplatin (CDDP)-based therapy. However, among the different types of cancers treated with CDDP, OvCa commonly develops chemoresistance to this treatment. The small extracellular vesicles (sEVs) play a central role in chemoresistance. In response to chemotherapy, resistant cells secrete sEVs named chemo-sEVs characterized by spe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f44d8412-0bfe-51b9-929f-da3a5715657b
DOI
10.1101/2023.02.03.526974
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chemo-sEVs release in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal functionDOI 10.1101/2023.02.03.526974
Select a neighboring publication to make it the new centre.